Bruce L. A. Carter, Director at Mirati Therapeutics, Inc. (MRTX), sold 2,250 shares at $190.50 ($430K) on 2021-02-02, disclosed to the SEC on 2021-02-03.
Open-market sale of $430k MRTX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $190.50 | 1,732 | $330K | 76.7% |
| 2 | $192.32 | 300 | $58K | 13.4% |
| 3 | $194.38 | 218 | $42K | 9.9% |
| Total | $191.12 avg | 2,250 | $430K | 100% |
| Filing → |
| MRTX | SELL | 2021-04-06 | $746K | — | Filing → |
| MRTX | SELL | 2020-12-16 | $1.1M | — | Filing → |
| MRTX | SELL | 2020-08-13 | $378K | — | Filing → |